1
|
Perez MG, Tanasie G, Neree AT, Suarez NG, Lafortune C, Paquin J, Marcocci L, Pietrangeli P, Annabi B, Mateescu MA. P19-derived neuronal cells express H 1, H 2, and H 3 histamine receptors: a biopharmaceutical approach to evaluate antihistamine agents. Amino Acids 2023:10.1007/s00726-023-03273-6. [PMID: 37171719 DOI: 10.1007/s00726-023-03273-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Accepted: 04/25/2023] [Indexed: 05/13/2023]
Abstract
Histamine is a biogenic amine implicated in various biological and pathological processes. Convenient cellular models are needed to screen and develop new antihistamine agents. This report aimed to characterize the response of neurons differentiated from mouse P19 embryonal carcinoma cells to histamine treatment, and to investigate the modulation of this response by antihistamine drugs, vegetal diamine oxidase, and catalase. The exposure of P19 neurons to histamine reduced cell viability to 65% maximally. This effect involves specific histamine receptors, since it was prevented by treatment with desloratadine and cimetidine, respectively, H1 and H2 antagonists, but not by the H3 antagonist ciproxifan. RT-PCR analysis showed that P19 neurons express H1 and H2 receptors, and the H3 receptor, although it seemed not involved in the histamine effect on these cells. The H4 receptor was not expressed. H1 and H2 antagonists as well as vegetal diamine oxidase diminished the intracellular Ca2+ mobilization triggered by histamine. The treatment with vegetal diamine oxidase or catalase protected against mortality and a significant reduction of H2O2 level, generated from the cells under the histamine action, was found upon treatments with desloratadine, cimetidine, vegetal diamine oxidase, or catalase. Overall, the results indicate the expression of functional histamine receptors and open the possibility of using P19 neurons as model system to study the roles of histamine and related drugs in neuronal pathogenesis. This model is less expensive to operate and can be easily implemented by current laboratories of analysis and by Contract Research Organizations.
Collapse
Affiliation(s)
- Mariela Gomez Perez
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Georgiana Tanasie
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Armelle Tchoumi Neree
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Narjara Gonzalez Suarez
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
- Chaire en Prévention et Traitement du Cancer, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Clara Lafortune
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Joanne Paquin
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Lucia Marcocci
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185, Rome, Italy
| | - Paola Pietrangeli
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185, Rome, Italy
| | - Borhane Annabi
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
- Chaire en Prévention et Traitement du Cancer, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada
| | - Mircea Alexandru Mateescu
- Department of Chemistry and CERMO FC Center, Université du Québec à Montréal, C. P. 8888, Montréal, QC, H3C 3P8, Canada.
| |
Collapse
|
2
|
Liang XG, Chen B, Shao LX, Cheng J, Huang MZ, Chen Y, Hu YZ, Han YF, Han F, Li X. A Fluorogenic Probe for Ultrafast and Reversible Detection of Formaldehyde in Neurovascular Tissues. Am J Cancer Res 2017; 7:2305-2313. [PMID: 28740553 PMCID: PMC5505062 DOI: 10.7150/thno.19554] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2017] [Accepted: 03/16/2017] [Indexed: 12/19/2022] Open
Abstract
Formaldehyde (FA) is endogenously produced in live systems and has been implicated in a diverse array of pathophysiological processes. To disentangle the detailed molecular mechanisms of FA biology, a reliable method for monitoring FA changes in live cells would be indispensable. Although there have been several fluorescent probes reported to detect FA, most are limited by the slow detection kinetics and the intrinsic disadvantage of detecting FA in an irreversible manner which may disturb endogenous FA homeostasis. Herein we developed a coumarin-hydrazonate based fluorogenic probe (PFM) based on a finely-tailored stereoelectronic effect. PFM could respond to FA swiftly and reversibly. This, together with its desirable specificity and sensitivity, endows us to track endogenous FA in live neurovascular cells with excellent temporal and spatial resolution. Further study in the brain tissue imaging showed the first direct observation of aberrant FA accumulation in cortex and hippocampus of Alzheimer's mouse model, indicating the potential of PFM as a diagnostic tool.
Collapse
|
3
|
García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Ayuso P, Navacerrada F, Agúndez JAG, Jiménez-Jiménez FJ. Diamine Oxidase rs10156191 and rs2052129 Variants Are Associated With the Risk for Migraine. Headache 2015; 55:276-86. [DOI: 10.1111/head.12493] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2014] [Indexed: 12/24/2022]
Affiliation(s)
- Elena García-Martín
- Department of Biochemistry and Molecular Biology; University of Extremadura; Cáceres Spain
- Red de Investigación de reacciones adversas a alergenos y fármacos; Instituto de Salud Carlos III; Madrid Spain
| | - Carmen Martínez
- Red de Investigación de reacciones adversas a alergenos y fármacos; Instituto de Salud Carlos III; Madrid Spain
- Department of Pharmacology; University of Extremadura; Badajoz Spain
| | - Mercedes Serrador
- Department of Family Medicine; Hospital “Príncipe de Asturias,”; Universidad de Alcalá; Madrid Spain
| | - Hortensia Alonso-Navarro
- Section of Neurology; Hospital Universitario del Sureste; Arganda del Rey (Madrid) Spain
- Department of Medicine-Neurology; Hospital “Príncipe de Asturias,”; Universidad de Alcalá; Madrid Spain
| | - Pedro Ayuso
- Department of Biochemistry and Molecular Biology; University of Extremadura; Cáceres Spain
- Red de Investigación de reacciones adversas a alergenos y fármacos; Instituto de Salud Carlos III; Madrid Spain
| | - Francisco Navacerrada
- Section of Neurology; Hospital Universitario del Sureste; Arganda del Rey (Madrid) Spain
- Service of Neurology; Hospital “Ramón y Cajal,”; Universidad de Alcalá; Madrid Spain
| | - José A. G. Agúndez
- Red de Investigación de reacciones adversas a alergenos y fármacos; Instituto de Salud Carlos III; Madrid Spain
- Department of Pharmacology; University of Extremadura; Cáceres Spain
| | - Félix Javier Jiménez-Jiménez
- Section of Neurology; Hospital Universitario del Sureste; Arganda del Rey (Madrid) Spain
- Department of Medicine-Neurology; Hospital “Príncipe de Asturias,”; Universidad de Alcalá; Madrid Spain
| |
Collapse
|
4
|
Tulpule K, Schmidt MM, Boecker K, Goldbaum O, Richter-Landsberg C, Dringen R. Formaldehyde induces rapid glutathione export from viable oligodendroglial OLN-93 cells. Neurochem Int 2012; 61:1302-13. [DOI: 10.1016/j.neuint.2012.09.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2012] [Revised: 09/04/2012] [Accepted: 09/13/2012] [Indexed: 12/29/2022]
|
5
|
Tulpule K, Dringen R. Formate generated by cellular oxidation of formaldehyde accelerates the glycolytic flux in cultured astrocytes. Glia 2012; 60:582-93. [PMID: 22258934 DOI: 10.1002/glia.22292] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2011] [Accepted: 12/16/2011] [Indexed: 01/12/2023]
Abstract
Formaldehyde is a neurotoxic compound that can be endogenously generated in the brain. Because astrocytes play a key role in metabolism and detoxification processes in brain, we have investigated the capacity of these cells to metabolize formaldehyde using primary astrocyte-rich cultures as a model system. Application of formaldehyde to these cultures resulted in the appearance of formate in cells and in a time-, concentration- and temperature-dependent disappearance of formaldehyde from the medium that was accompanied by a matching extracellular accumulation of formate. This formaldehyde-oxidizing capacity of astrocyte cultures is likely to be catalyzed by alcohol dehydrogenase 3 and aldehyde dehydrogenase 2, because the cells of the cultures contain the mRNAs of these formaldehyde-oxidizing enzymes. In addition, exposure to formaldehyde increased both glucose consumption and lactate production by the cells. Both the strong increase in the cellular formate content and the increase in glycolytic flux were only observed after application of formaldehyde to the cells, but not after treatment with exogenous methanol or formate. The accelerated lactate production was not additive to that obtained for azide, a known inhibitor of complex IV of the respiratory chain, and persisted after removal of formaldehyde after a formaldehyde exposure for 1.5 h. These data demonstrate that cultured astrocytes efficiently oxidize formaldehyde to formate, which subsequently enhances glycolytic flux, most likely by inhibition of mitochondrial respiration.
Collapse
Affiliation(s)
- Ketki Tulpule
- Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany
| | | |
Collapse
|
6
|
Tulpule K, Dringen R. Formaldehyde stimulates Mrp1-mediated glutathione deprivation of cultured astrocytes. J Neurochem 2011; 116:626-35. [PMID: 21166805 DOI: 10.1111/j.1471-4159.2010.07150.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Formaldehyde (Fal) is an environmental neurotoxin that is also endogenously produced in brain. Since the tripeptide glutathione (GSH) plays an important role in detoxification processes in brain cells, we have investigated the consequences of a Fal exposure on the GSH metabolism of brain cells, using astrocyte-rich primary cultures as model system. Treatment of these cultures with Fal resulted in a rapid time- and concentration-dependent depletion of cellular GSH and a matching increase in the extracellular GSH content. Exposure of astrocytes to 1mm Fal for 3h did not compromise cell viability but almost completely deprived the cells of GSH. Half-maximal deprivation of cellular GSH was observed after application of 0.3mm Fal. This effect was rather specific for Fal, since methanol, formate or acetaldehyde did not affect cellular GSH levels. The Fal-stimulated GSH loss from viable astrocytes was completely prevented by semicarbazide-mediated chemical removal of Fal or by the application of MK571, an inhibitor of the multidrug resistance protein 1. These data demonstrate that Fal deprives astrocytes of cellular GSH by a multidrug resistance protein 1-mediated process.
Collapse
Affiliation(s)
- Ketki Tulpule
- Centre for Biomolecular Interactions Bremen, University of Bremen, Bremen, Germany
| | | |
Collapse
|
7
|
Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. INTERNATIONAL REVIEW OF NEUROBIOLOGY 2011; 100:13-42. [PMID: 21971001 DOI: 10.1016/b978-0-12-386467-3.00002-9] [Citation(s) in RCA: 95] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Abstract
Monoamine oxidase (MAO) isoenzymes A and B are mitochondrial-bound proteins, catalyzing the oxidative deamination of monoamine neurotransmitters as well as xenobiotic amines. Although they derive from a common ancestral progenitor gene, are located at X-chromosome and display 70% structural identity, their substrate preference, regional distribution, and physiological role are divergent. In fact, while MAO-A has high affinity for serotonin and norepinephrine, MAO-B primarily serves the catabolism of 2-phenylethylamine (PEA) and contributes to the degradation of other trace amines and dopamine. Convergent lines of preclinical and clinical evidence indicate that variations in MAO enzymatic activity--due to either genetic or environmental factors--can exert a profound influence on behavioral regulation and play a role in the pathophysiology of a large spectrum of mental and neurodegenerative disorders, ranging from antisocial personality disorder to Parkinson's disease. Over the past few years, numerous advances have been made in our understanding of the phenotypical variations associated with genetic polymorphisms and mutations of the genes encoding for both isoenzymes. In particular, novel findings on the phenotypes of MAO-deficient mice are highlighting novel potential implications of both isoenzymes in a broad spectrum of mental disorders, ranging from autism and anxiety to impulse-control disorders and ADHD. These studies will lay the foundation for future research on the neurobiological and neurochemical bases of these pathological conditions, as well as the role of gene × environment interactions in the vulnerability to several mental disorders.
Collapse
Affiliation(s)
- Marco Bortolato
- Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, USA
| | | |
Collapse
|
8
|
Reversible inactivation of bovine plasma amine oxidase by cysteamine and related analogs. Biochem Biophys Res Commun 2010; 403:442-6. [PMID: 21094148 DOI: 10.1016/j.bbrc.2010.11.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2010] [Accepted: 11/13/2010] [Indexed: 11/23/2022]
Abstract
Cysteamine (1) was reported many years ago to reversibly inhibit lentil seedling amine oxidase, through the formation of a complex with thioacetaldehyde, the turnover product of 1. Herein, cysteamine (1) and its analogs 2-(methylamino)ethanethiol (3) and 3-aminopropanethiol (6) were found to be reversible inhibitors of bovine plasma amine oxidase (BPAO), but 2-(methylthio)ethylamine (7) was determined to be a weak irreversible inhibitor of BPAO. Based on our results, indicating the necessity of a sulfhydryl-amine for reversible inactivation of BPAO, the failure of inhibited BPAO to recover activity after gel filtration, the first-order kinetics of activity recovery upon dialysis, and 2,4,6-trihydroxyphenylalanine quinine (TPQ) cofactor transformation which indicated from the results of phenylhydrazine titration and substrate protection, we propose a mechanism for the reversible inactivation of BPAO by 1 involving the formation of a cofactor adduct, thiazolidine, between BPAO and 1.
Collapse
|
9
|
García-Martín E, Martínez C, Benito-León J, Calleja P, Díaz-Sánchez M, Pisa D, Alonso-Navarro H, Ayuso-Peralta L, Torrecilla D, Agúndez JAG, Jiménez-Jiménez FJ. Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis. Eur J Neurol 2009; 17:335-8. [PMID: 19538200 DOI: 10.1111/j.1468-1331.2009.02720.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Histamine N-methyltransferase (HNMT) is the main metabolizing enzyme of histamine (a mediator of inflammation implicated in the pathogenesis of multiple sclerosis-MS) in the CNS. We have investigated the possible association between a single nucleotide polymorphism of the HNMT (chromosome 2q22.1), that causes the amino acid substitution Thr105Ile (decreasing enzyme activity) and the risk for MS. METHODS We studied the frequency of the HNMT genotypes and allelic variants in 228 MS patients and 295 healthy controls using a PCR-RLFP method. RESULTS The frequencies of the HNMT genotypes and allelic variants did not differ significantly between MS patients and controls, and were unrelated with the age of onset of MS, gender, and course of MS. CONCLUSION The HNMT polymorphism is not related with the risk for MS.
Collapse
Affiliation(s)
- E García-Martín
- Biochemistry-Molecular Biology Department, University of Extremadura, Badajoz, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, Jiménez-Jiménez FJ. Histamine-N-Methyl Transferase Polymorphism and Risk for Migraine. Headache 2008; 48:1343-8. [DOI: 10.1111/j.1526-4610.2007.01056.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Nonsynonymous Polymorphisms of Histamine-Metabolising Enzymes in Patients with Parkinson’s Disease. Neuromolecular Med 2007; 10:10-6. [DOI: 10.1007/s12017-007-8017-7] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/18/2007] [Indexed: 11/25/2022]
|
12
|
Obata T. Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum. Toxicology 2006; 222:46-52. [PMID: 16500014 DOI: 10.1016/j.tox.2006.01.023] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2005] [Revised: 12/27/2005] [Accepted: 01/20/2006] [Indexed: 10/25/2022]
Abstract
The present study was examined whether tamoxifen, a synthetic nonsteroidal antiestrogen, could suppress antidepressant drug phenelzine can increase an active dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP(+))-induced hydroxyl radical (OH) generation in the extracellular fluid of rat striatum, using in vivo microdialysis system. Rats were anesthetized, and sodium salicylate (0.5 nmol/microl/min) was infused through a microdialysis probe to detect the generation of OH as reflected by the non-enzymatic formation of 2,3-dihydroxybenzoic acid (DHBA) in the striatum. Infusion of phenelzine (100 microM or 0.1 nmol/microl/min) into the striatum drastically increased dopamine (DA) efflux and the OH formation, trapped as 2,3-DHBA by the possible increased production of MPP(+). However, tamoxifen (100 microM) significantly suppressed phenelzine enhanced DA efflux and OH formation by MPP(+). These results in the present study is the first demonstration showing the protective effect of tamoxifen on OH generation induced by phenelzine enhanced MPP(+) by suppressing DA efflux.
Collapse
Affiliation(s)
- Toshio Obata
- Department of Analytical Chemistry, Ohu University, School of Pharmaceutical Sciences, Koriyama, Fukushima 963-8611, Japan.
| |
Collapse
|
13
|
Roessner V, Uebel H, Becker A, Beck G, Bleich S, Rothenberger A. Serum level of semicarbazide-sensitive amine oxidase in children with ADHD. Behav Brain Funct 2006; 2:5. [PMID: 16441883 PMCID: PMC1373638 DOI: 10.1186/1744-9081-2-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2005] [Accepted: 01/27/2006] [Indexed: 11/12/2022] Open
Abstract
Background The objective of this study was to analyze the extracellularly acting semicarbazide-sensitive amine oxidase (SSAO) serum levels in children with ADHD for the first time. SSAO is known to show deviations from normal in various somatic disorders and to interplay with the intracellularly active MAO. In humans two forms of SSAO a circulating form in plasma and a membrane-bound form are involved in monoaminergic metabolism. Methods We analyzed serum levels of SSAO in 27 children meeting ICD-10 criteria of Hyperkinetic Disorder (F90) or DSM-IV criteria of ADHD combined type by HPLC method and fluorimetric detection. A group of 42 healthy volunteers within the same age range (7.0 – 14.0 years) served as controls. Results No significant differences between children with ADHD (SSAO activity M = 773, SD = 217 mU/l) and healthy controls (SSAO activity M = 775, SD = 256 mU/l) in SSAO serum levels were found (F = 2.18; p > 0.14). Further, stimulant medication status had no influence on the result (F = 2.52; p > 0.11). Conclusion There is no evidence for a deviation of SSAO serum activity in ADHD. Hence, extracellularly acting SSAO does not seem to be a promising factor for further research in ADHD. But progress in knowledge of its physiologic role and of the relationship between the membrane-bound and the circulating serum form may open new avenues for research on SSAO in ADHD.
Collapse
Affiliation(s)
- Veit Roessner
- Department of Child and Adolescent Psychiatry, University of Goettingen, Von-Siebold-Str. 5, D-37075 Goettingen, Germany
| | - Henrik Uebel
- Department of Child and Adolescent Psychiatry, University of Goettingen, Von-Siebold-Str. 5, D-37075 Goettingen, Germany
| | - Andreas Becker
- Department of Child and Adolescent Psychiatry, University of Goettingen, Von-Siebold-Str. 5, D-37075 Goettingen, Germany
| | - Georg Beck
- Department of Psychiatry and Psychotherapy, University of Erlangen, Schwabachanlage 6, D-91054 Erlangen, Germany
| | - Stefan Bleich
- Department of Psychiatry and Psychotherapy, University of Erlangen, Schwabachanlage 6, D-91054 Erlangen, Germany
| | - Aribert Rothenberger
- Department of Child and Adolescent Psychiatry, University of Goettingen, Von-Siebold-Str. 5, D-37075 Goettingen, Germany
| |
Collapse
|
14
|
Jeon HB, Sayre LM. Highly potent propargylamine and allylamine inhibitors of bovine plasma amine oxidase. Biochem Biophys Res Commun 2003; 304:788-94. [PMID: 12727226 DOI: 10.1016/s0006-291x(03)00681-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Propargylamine was reported many years ago to be a mechanism-based inhibitor of bovine plasma amine oxidase (BPAO), though the potency was modest and allylamine was a substrate. Herein, selected 3-substituted propargylamines and allylamines were found to be potent time-dependent inactivators of BPAO, exhibiting IC(50) values of 2-13 microM at 30 degrees C, making them the most potent BPAO inhibitors reported to date. The most potent compound, trans-3-chloroallylamine, was previously found not to inhibit the flavin-dependent monoamine oxidase (the cis isomer did), and thus appears to be a highly selective inhibitor.
Collapse
Affiliation(s)
- Heung-Bae Jeon
- Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA
| | | |
Collapse
|